Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Nicolle

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Muscle & Nerve|October 1, 1996
Lambert-Eaton myasthenic syndrome presenting with severe respiratory failureM W Nicolle, D J Stewart, H Remtulla, et al.
Muscle & Nerve|May 8, 1998
Diagnostic difficulties in myasthenia gravisJ Maher, F Grand'Maison, M W Nicolle, et al.
Annals of the New York Academy of Sciences|June 21, 1993
An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptideM W Nicolle, A Vincent, S Sharma, et al.
Journal of Neurology|June 28, 2019
Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndromeA Budhram, A Mirian, C Le, et al.
Muscle & Nerve|May 16, 2001
Wartenberg's migrant sensory neuritisM W Nicolle, J R Barron, B V Watson, et al.
Neurology|July 13, 2006
Sleep apnea in patients with myasthenia gravisM W Nicolle, S Rask, W J Koopman, et al.
The Journal of Clinical Investigation|April 1, 1994
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexesM W Nicolle, B Nag, S D Sharma, et al.
Neurology|December 22, 1999
A novel sodium channel mutation in a family with hypokalemic periodic paralysisD E Bulman, K A Scoggan, M D van Oene, et al.
Neurology|April 25, 2008
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravisD B Sanders, I K Hart, R Mantegazza, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Muscle & Nerve|October 1, 1996
Lambert-Eaton myasthenic syndrome presenting with severe respiratory failureM W Nicolle, D J Stewart, H Remtulla, et al.
Muscle & Nerve|May 8, 1998
Diagnostic difficulties in myasthenia gravisJ Maher, F Grand'Maison, M W Nicolle, et al.
Annals of the New York Academy of Sciences|June 21, 1993
An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptideM W Nicolle, A Vincent, S Sharma, et al.
Journal of Neurology|June 28, 2019
Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndromeA Budhram, A Mirian, C Le, et al.
Muscle & Nerve|May 16, 2001
Wartenberg's migrant sensory neuritisM W Nicolle, J R Barron, B V Watson, et al.
Neurology|July 13, 2006
Sleep apnea in patients with myasthenia gravisM W Nicolle, S Rask, W J Koopman, et al.
The Journal of Clinical Investigation|April 1, 1994
Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexesM W Nicolle, B Nag, S D Sharma, et al.
Neurology|December 22, 1999
A novel sodium channel mutation in a family with hypokalemic periodic paralysisD E Bulman, K A Scoggan, M D van Oene, et al.
Neurology|April 25, 2008
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravisD B Sanders, I K Hart, R Mantegazza, et al.
Pageof 2